Concurrent Chemoradiotherapy in Resected Extrahepatic Cholangiocarcinoma

Keyphrases

• Radiotherapy 100%
• Local Control 100%
• Concurrent Chemoradiotherapy 100%
• Chemoradiotherapy 100%
• Extrahepatic Cholangiocarcinoma 100%
• Surgical Morbidity 100%
• Distant Failure 100%
• Survivors 50%
• Chemotherapy 50%
• Treatment Strategy 50%
• 5-year Survival 50%
• Advanced Disease 50%
• Long-term Survival 50%
• Improved Survival 50%
• Adjuvant Radiotherapy 50%
• Systemic Therapy 50%
• Resection 50%
• Median Survival 50%
• Retrospective Analysis 50%
• Overall Survival 50%
• Rare Malignancy 50%
• Survival Benefit 50%
• Univariate Analysis 50%
• Disease-free Survival 50%
• Tumor Resectability 50%
• Fluoropyrimidine-based Chemotherapy 50%
• Local Failure 50%
• Failure Pattern 50%
• Perineural Involvement 50%
• Postoperative Setting 50%
• Survival Outcomes 50%
• Radical Resection 50%
• Metastasis-free Survival 50%
• R0 Resection 50%
• Biliary Cancer 50%
• Locoregional Control Rate 50%
• Control Benefits 50%

Medicine and Dentistry

• Chemoradiotherapy 100%
• Cholangiocarcinoma 100%
• Diseases 50%
• Radiation Therapy 50%
• Neoplasm 25%
• Cancer 25%
• Adjuvant Radiotherapy 25%
• Systemic Therapy 25%
• Overall Survival 25%
• Univariate Analysis 25%
• Disease Free Survival 25%
• Bile Duct Cancer 25%
• Metastasis Free Survival 25%
• Radical Resection 25%
• Fluoropyrimidine 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemoradiation Therapy 100%
• Bile Duct Carcinoma 100%
• Chemotherapy 50%
• Diseases 50%
• Neoplasm 25%
• Overall Survival 25%
• Disease Free Survival 25%
• Bile Duct Cancer 25%
• Fluoropyrimidine 25%
• Metastasis Free Survival 25%